Skip to content
Delivering the Goods episode artwork

Sep 25, 2024 36 min

Delivering the Goods

from The Bio Report Hosted by Levine Media Group

Nearly 70 percent of patients with chronic conditions fail to take their medicines as prescribed. This can lead to poor outcomes and greater healthcare costs. Vivani Medical, which has developed implantable drug delivery technology, said it can provide steady drug release for up to six months with a single implant. This not only can address the problem of non-compliance, but can also reduce side effects associated with fluctuating drug release from conventional delivery methods. We spoke to Adam Mendelsohn, CEO of Vivani Medical, about its implantable drug delivery technology, how it works, and why its lead indication is a GLP-1 implant for weight loss and diabetes.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Delivering the Goods

0:00 36:06

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of The Bio Report?

This episode is 36 minutes long.

When was this The Bio Report episode published?

This episode was published on September 25, 2024.

Can I download this The Bio Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.